Rebel
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
OK, I said, "Makes me wonder..." That is misleading? lol OK then. Anyone who knows anything about Arrayit and its technology should be "wondering" too because the similarities could be more than just a coincidence. And give me a break, I have not "suggested" anything.
There is no indication anywhere that their technology is in dispute. You cannot make that assumption because their first attempt placed them on the FDA's "pre-emergency use authorization" list, which clearly indicates the FDA was expecting a follow-up or improved test from Arrayit.
Please give readers of this board a little credit. They're not stupid, you know, and would not invest in a company because someone is "wondering." That is just silly.
If Arrayit received 100% proficiency scores from the third party, independent lab, American College of Pathologists, for their allergy and asthma tests, then why couldn't they achieve the same for their Covid-19 test or tests? Also, it should be remembered that Arrayit received Medicare Part B approval for those very allergy/asthma tests. So no, I don't think the technology is in dispute.
Arrayit Corporation Scores 100% on Proficiency Testing Conducted by the College of American Pathologists...
"Sunnyvale, CA, May 16, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces that the company scored 100% on clinical laboratory proficiency testing conducted by the College of American Pathologists (CAP). Arrayit received a perfect score in highly quantitative measurements of immunoglobulin E (IgE), the antibodies in the human bloodstream indicative of allergy and asthma. The CAP SA2018 Diagnostic Immunology Survey proficiency test included 1,677 clinical laboratories utilizing IgE testing equipment manufactured by major corporations in the life sciences, molecular diagnostics and pharmaceutical markets. CAP, the international proficiency testing leader, ensures and improves healthcare quality by fostering clinical excellence through the impartial and carefully-supervised proficiency testing process.
Arrayit uses its patented and proprietary microarray technology to accurately and rapidly test IgE levels in patient blood card specimens shipped to its Silicon Valley clinical laboratory by hospitals, health maintenance organizations (HMOs), clinical laboratories, insured patients in physician groups, and consumers through the assistance of a medical doctor. Arrayit leverages miniaturization, allergen and sample multiplexing, and a high degree of robotic and software automation to deliver test results quickly and non-invasively using finger stick blood sampling."
https://www.marketscreener.com/quote/stock/ARRAYIT-CORPORATION-120792591/news/Arrayit-Corporation-Scores-100-on-Proficiency-Testing-Conducted-by-the-College-of-American-Patholog-26596357/
Is it a fact that Arrayit's technology is in dispute? Answer: No. is it a fact that Arrayit's tests are in dispute or not viable? Answer: No. Is it a fact that the latest court documents indicated the company is still operating, albeit in a very limited capacity. Answer: Yes.
I think everyone is well aware of the problems with ARYC and don't need to be reminded constantly. I was simply sharing this information because it is INTERESTING that the test described sounds EXACTLY like Arrayit's test.
Sharing information has nothing to do with "facing facts."
FDA grants first COVID-19 antibody green light for at-home, fingerprick blood test
Makes me wonder if Arrayit has/had anything to do with this test since it sounds exactly like ARYC's test that was improved to "close to 100% accuracy."
https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-issues-emergency-use-authorization-symbiotica-covid-19-self
18.9 million in the float; 12% short.
Awesome! So does this mean a total of 2175 units have been delivered in just one month?
I thought of that, and while it would sure be convenient geographically, I am not sure if Tim has the adventurous spirit that would be required. ARYC needs a rocket man.
The Bill and Melinda Gates Foundation and/or Elon may be interested in Arrayit's technology. Elon especially loves to take risks and they both want to save the world. Imagine the fun. .SWOOOOSH--KABOOOOM. lol.
Maybe the FDA is still interested too.
It does appear some person or entity is quietly accumulating shares.
According to the latest motion and Order, Mark was not to do Covid testing, but the court did allow him to continue working at the lab, but it was Mark's decision to stay away as a cautionary measure, It sounded like they're still open but in a very limited capacity, i.e., selling testing equipment.and supplies.
The entire staff is not under indictment.
When did PSA ever state or infer such a thing?
My reading level has nothing to do with it.
Not sure if this was posted already: "Having read and considered the papers and being fully informed, and for good cause showing, the Court GRANTS the defendant’s motion and MODIFIES the terms and conditions of release to remove the requirement that Mr. Schena post a bond security by the equity in his house and to release the bond posed by Mr. Schena at Docket No. 28. The Clerk of the Court shall issue a deed of reconveyance to be submitted by Mr. Schena upon entry of this Order.
IT IS SO FOUND AND SO ORDERED.
2/10/2020
HON. LAUREL BEELER United States Magistrate Judge"
Absolutely wrong. What is easy to understand is that collusion is not mentioned in any complaint or court document. Just because it is discussed regularly on this board does not mean it's true or proven.
The completed story is that Avant was purchased by OncBioMune (OBMP) in June, 2020 and OvaDx was NOT part of the deal, so it's logical to assume that it went back to ARYC. Plus, the original sale to Avant gave Arrayit the exclusive right to manufacture OvaDx. And, as you mentioned, OvaDx is still appearing on their website, which is interesting.
What? It is Arrayit's very own test that took 10 years to develop. I have not twisted anything about OvaDx. He asked me a specific question and I answered. Bringing up all that other stuff doesn't change the answer.
The university lawsuit is settled and closed, by the way. Arrayit will pay them back.
It would be worth a lot if the OvaDx ducks were all in a row and legitimate, but that remains a mystery since we haven't heard much about OvaDx in a few years. Is this the "major microarray technology product line" that Arrayit submitted to the FDA in 2018? And what is the status now? Unfortunately, we just don't know. With everything that has happened, one has to wonder if Mark's meeting with the FDA really happened, despite the photo of him standing right there at the FDA headquarters. One has to also wonder about the other tests in their pipeline, which tests are still mentioned in the ARYC website.
Here is an excerpt from an article written in 2013, which explains how the test would save women and billions of dollars in healthcare costs, and provide "$975 million" to Arrayit's revenue.
"It does not seem an exaggeration to say that the OvaDx® test would deliver a substantial benefit to ovarian cancer patients and to the nation by reducing costs in the healthcare system. Extrapolating information from the NCI and others, nearly 10 percent of adult women in the U.S. run an elevated risk of ovarian cancer and should be tested every five years, meaning that approximately 1.5 million tests should be conducted annually. At a $650-per-test price point, sales would total $975 million annually for Arrayit.
$975 million in testing could potentially reduce ovarian cancer deaths by more about 80 percent (based upon cumulative specificity modeling as noted above), meaning that running a 2.5-hour OvaDx® screen could save about 12,000 women’s lives each year and more than $3.1 billion in associated healthcare costs."
http://ca.finance.yahoo.com/news/could-arrayits-early-ovarian-cancer-140000271.html
lol. I made NO such claim!
lol. Yes you did.
"OvaDX never amounted to anything. It was sold off many years ago to another company (Avant Diagnostics - who was also suspended to the Grey Market, and then eventually had its registration revoked and was delisted)."
That is exactly what you said.
No, OvaDx was not included in the asset sale of Avant to OncBioMune (OBMP) and "probably" reverted back to Arrayit. But from the beginning, Arrayit's agreement with Avant gave ARYC the exclulsive right to MANUFACTURE OvaDx for Avant Diagnostics.
Well, I can't make an intelligent guess without much more information.
We're mostly talking about Arrayit's allergy, Covid 19, and Pinnertests, as well as their tests for ovarian cancer and Parkinson's, and whatever "major product line" they submitted to the FDA a few years back, AND of course their microarray technology. We just don't know where all of that stands.
Please read this post in reply to lmd:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=161861714
That's the new lawsuit against Rene, which has or soon will be settled. Yes, I see Arrayit is named in that one.
There are NO lies in my post, or in any of my posts.
No, Arrayit the corporation is not being sued by the DOJ or SEC.
No one knows if anything is "all gone." Their tests may be fine. We just don't know the status of the technology and/or the tests at this point. None of the court documents said their tests didn't work or that the technology was bogus. All we know is that the first submission of the Covid test to the FDA was not at acceptable levels so they were placed on the pre-emergency authorization list, and as you recall, their new and improved Covid test is "close to 100%" in specificity and sensitivity according to the brief filed with the court.
The above is just a reminder...
A comment made by PSA doesn't prove anything. In fact, it sounds like he was not happy about it.
Yes, it is a much better alternative than the scratch test. Since it went through several proficiency tests and was approved by Medicare, one would think the test must be viable...then there's also Pinnertest. And what about the FDA submission and their ovarian cancer and Parkinson's tests? And we still don't know for sure how their new and improved Covid-19 test performs ("close to 100%").
My post was about Jason Nielsen.
No. We are talking about Jason Nielsen's case. The question remains: Why did the SEC not charge him with being a co-conspirator with Mark?
If and when a such a charge is made there might be something to talk about, but until then it's a moot point.
Huh??
lol.. And??? You must have missed my most recent post on that very subject.
Show me the proof that Mark and Jason were conspiring together. If the SEC decides that they were, then their complaint will have to be amended and then proven in court. It is not a matter of anyone's opinion. Let it all be revealed. That's all everyone wants.
Not true. The simple question is: If Jason and Mark were conspiring, why was Jason NOT charged with it? Apparently it was NOT "obvious."
That is the common sense question.
Jason hasn't been charged with being in conspiracy with Mark. Let's stick to the facts.
No, it is not incorrect. It's free speech. Lying on stock message boards is AOK, unfortunately. You can cite as many rules as you want, but as I said, he did nothing more than hundreds of posters do every single day. If they're going to charge him, they should go after every single poster who posted lies here, and there are many.
I think he truly believed that. Unless he and Mark were in cahoots, he should not be punished. From all accounts, he was a serious investor and believer in ARYC and must still hold many millions of shares. What he did was post on an IHub message board and that is not a crime, even if you lie. There are plenty of lies posted on this board by others, and those people should face similar charges if they're going to punish Jason. And "spoofing" is done all day, every day by those who are trying to manipulate the share price.
The professor stated: "Any outside investors probably have dumped their stock..."
I don't think that is true, and it appears there is still some interest in purchasing ARYC stock.
ARYC has not been a public company for 27 years - it went public in 2009.
Who knows? Maybe there's something behind it, or maybe not. Sub penny stocks have been moving up lately after years of doing nothing. Could be that people are just taking shots in the dark or could be something more. I mean, we still don't know everything, especially about their products and technology. The company has existed for over 27 years and didn't survive on air. Maybe Reddit is planning something. lol.
Curiouser and curiouser...